2016 Progress Report: Organotypic Culture Model to Analyze Developmental LimbMalformationsResulting from Toxicant/Teratogen Exposure

EPA Grant Number: R835736C002
Subproject: this is subproject number 002 , established and managed by the Center Director under grant R835736
(EPA does not fund or establish subprojects; EPA awards and manages the overall grant for this center).

Center: Vanderbilt Pittsburgh Resource for Organotypic Models for Predictive Toxicology
Center Director: Hutson, Michael Shane
Title: Organotypic Culture Model to Analyze Developmental LimbMalformationsResulting from Toxicant/Teratogen Exposure
Investigators: Tuan, Rocky
Institution: University of Pittsburgh Main Campus , Vanderbilt University
EPA Project Officer: Klieforth, Barbara I
Project Period: December 1, 2014 through November 30, 2018 (Extended to November 30, 2019)
Project Period Covered by this Report: December 1, 2015 through November 30,2016
RFA: Organotypic Culture Models for Predictive Toxicology Center (2013) RFA Text |  Recipients Lists
Research Category: Safer Chemicals , Health , Human Health

Objective:

Our goal is to develop robust in vitro three-dimensional (3D) organotypic culture models (OCMs) based on human mesenchymal stem cells (MSCs) to first examine critical phenomena of embryonic limb development that are prime targets of limb teratogenesis, and then examine their susceptibility to perturbation by known and candidate teratogens and environmental toxicants.

Progress Summary:

Project 2 has demonstrated that, like 10 µL 40,000 cell cultures, 2 µL micromass cultures containing 40,000 adult human MSCs undergo chondrogenesis (OCM1) and hypertrophy (OCM2)—a scale more amenable to medium throughput assays. The transduction conditions and function of virally-delivered promoter-reporter constructs for specific signaling pathways relevant to different stages of skeletal development have been shown in control chondrogenic cultures (OCM1)—allowing for real-time, non-invasive analysis of stress response and differentiation of the cultures. A bioreactor for mechanical stimulation of cartilage to activate joint-specific gene expression (OCM3, version 1) has been fabricated by Project 5, tested by Project 2 and found to have mechanical and biological short-comings that require a re-design—OCM3 version 2 is actively being tested. The ability of the cultures to develop on porous, polycarbonate membranes—a membrane used in other Project 5 microfluidic platforms—has been demonstrated and the specifications for microfluidically-enabled chondrogenic and hypertrophic cultures have been determined. Modifications to existing platforms developed by Project 5 are in development. In addition, 2 µL 40,000 cells micromass cultures have been shown to develop normally in liver medium, indicating that direct connection of limb cultures downstream of liver is feasible. 

Figure 1. Organotypic culture design. (A-C) Development of the axial cartilaginous skeletal model. (A) The limb bud, the earliest morphogenic indication of limb development, is a protrusion from the lateral plate mesoderm that is initially comprised of the ectoderm overlying specified but undifferentiated mesenchymal cells that proliferate, condense, and differentiate into cartilage. (B) As the limb bud grows and elongates, the cartilage matures and undergoes hypertrophy, a step required for future endochondral ossification. (C) The process of joint formation involves alignment of cells along the site of the future joint forming the interzone that undergoes cavitation (shown in red) resulting in a joint space, proximal and distal joint surfaces and capsular lining. Stages of limb development can be replicated in vitro using a 3D planar high density micromass in various configurations. (D-F) Representative cultures using chick embryonic limb bud undergoing chondrogenesis, hypertrophy or segmentation stained with Alcian blue—specific for cartilage-specific sulfated proteoglycans.

Future Activities:

Project 2 will complete assessment of signal transduction promoter-reporter constructs and differentiation stage-specific promoter-reporter constructs, including a correlation between promoter activity (the surrogate) and actual target gene activity under control conditions and a means to quantify promoter activity. We also will test the utility of matrix anabolic processing and catabolic degradation products from the medium using ELISAs. Project 2 will continue to work with Project 5 in the development of a mechanical stimulator for the joint segmentation model. Once the model is developed, we will begin characterization of tissue development by RT-PCR, histology, and promoter-reporter activity.

Microfluidically-enabled skeletal development models of chondrogenesis and hypertrophy will be developed and tested based on existing platforms developed by Project 5. This will place OCM1 and 2 in a platform common to other tissue models in the project and allow direct connection of limb models to other systems. Project 2 will characterize OCM1 and 2 development in control liver-conditioned medium and that containing liver-processed teratogens using conditioned medium before directly connecting limb OCMs to liver OCM. Once the QAPP is approved, Project 2 will test known teratogens (currently VPA, warfarin, and thalidomide) on 2 µL 40,000 cell cultures in microfluidic platforms alone and in connection (direct or indirect) with liver OCMs. The tests will include correlating changes in culture development (by RT-PCR, histology, and promoter-reporter activity) with stress-responses and anticipated markers of the known adverse outcome pathways (AOP). The specific assays for AOP assessment are to be determined.


Journal Articles on this Report : 1 Displayed | Download in RIS Format

Other subproject views: All 6 publications 1 publications in selected types All 1 journal articles
Other center views: All 149 publications 39 publications in selected types All 39 journal articles
Type Citation Sub Project Document Sources
Journal Article Alexander PG, Clark KL, Tuan RS. Prenatal exposure to environmental factors and congenital limb defects. Birth Defects Research, Part C, Embryo Today: Reviews 2016;108(3):243-273. R835736 (2015)
R835736 (2016)
R835736 (2017)
R835736 (2018)
R835736C002 (2016)
  • Abstract from PubMed
  • Abstract: Wiley-Abstract
    Exit
  • Other: ResearchGate-Abstract
    Exit
  • Supplemental Keywords:

    limb development, organotypic culture model, high density micromass culture, adult human mesenchymal stem cell, MSC, chondrogenesis, hypertrophy, joint segmentation, three dimensional, 3D, limb bioreactor, mechanical stimulation, toxicology, valproic acid, warfarin, mifepristone

    Relevant Websites:

    University of Pittsburgh Center for Cellular and Molecular Engineering (CCME) Exit

    Vanderbilt-Pittsburgh Resource for Organotypic Models for Predictive Toxicology (VPROMPT) Exit

    Progress and Final Reports:

    Original Abstract
  • 2015 Progress Report
  • 2017 Progress Report
  • 2018

  • Main Center Abstract and Reports:

    R835736    Vanderbilt Pittsburgh Resource for Organotypic Models for Predictive Toxicology

    Subprojects under this Center: (EPA does not fund or establish subprojects; EPA awards and manages the overall grant for this center).
    R835736C001 Mammosphere Bioreactor For Life-Stage Specific Toxicology
    R835736C002 Organotypic Culture Model to Analyze Developmental LimbMalformationsResulting from Toxicant/Teratogen Exposure
    R835736C003 Validating a fetal membrane on a chip model for characterizing reproductive toxicant exposure risks
    R835736C004 Organotypic Liver Model for Predictive Human Toxicology and Metabolism
    R835736C005 Systems Engineering & Analysis for Organotypic Culture Models